Keros Therapeutics Inc
NASDAQ:KROS
Keros Therapeutics Inc
NASDAQ:KROS
Price:
10.61
USD
-4.24%
Market Closed
Market Cap:
$209.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Keros Therapeutics Inc
NASDAQ:KROS
|
US |
|
PDG Realty SA Empreendimentos e Participacoes
BOVESPA:PDGR3
|
BR |
|
B
|
Bhilwara Technical Textiles Ltd
BSE:533108
|
IN |
|
N
|
NR Spuntech Industries Ltd
TASE:SPNTC
|
IL |
|
Archi Indonesia Tbk PT
IDX:ARCI
|
ID |
|
A
|
Aker Biomarine ASA
OSE:AKBM
|
NO |
|
Elkem ASA
OSE:ELK
|
NO |
|
Avation PLC
LSE:AVAP
|
SG |
|
Astra International Tbk PT
OTC:PTAIY
|
ID |
|
W
|
Wee Hur Holdings Ltd
SGX:E3B
|
SG |
|
Marketech International Corp
TWSE:6196
|
TW |
|
Gozde Girisim Sermayesi Yatirim Ortakligi AS
IST:GOZDE.E
|
TR |
|
Primerica Inc
NYSE:PRI
|
US |
|
H
|
Hallmark Financial Services Inc
XBER:SSB
|
US |
Balance Sheet
Balance Sheet Decomposition
Keros Therapeutics Inc
Keros Therapeutics Inc
Balance Sheet Decomposition is not available for
Keros Therapeutics Inc
Keros Therapeutics Inc
Balance Sheet
Keros Therapeutics Inc
Keros Therapeutics Inc
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
23
|
7
|
266
|
230
|
279
|
331
|
560
|
287
|
|
| Cash Equivalents |
23
|
7
|
266
|
230
|
279
|
331
|
560
|
287
|
|
| Total Receivables |
0
|
1
|
0
|
18
|
0
|
0
|
3
|
6
|
|
| Accounts Receivables |
0
|
1
|
0
|
18
|
0
|
0
|
3
|
4
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Other Current Assets |
2
|
1
|
2
|
3
|
7
|
16
|
26
|
22
|
|
| Total Current Assets |
26
|
9
|
268
|
251
|
286
|
347
|
589
|
315
|
|
| PP&E Net |
1
|
2
|
2
|
2
|
18
|
19
|
23
|
21
|
|
| PP&E Gross |
1
|
2
|
2
|
2
|
18
|
19
|
23
|
21
|
|
| Accumulated Depreciation |
0
|
1
|
1
|
1
|
1
|
2
|
3
|
4
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
1
|
3
|
3
|
4
|
1
|
|
| Total Assets |
27
N/A
|
11
-60%
|
269
+2 349%
|
255
-5%
|
307
+20%
|
370
+21%
|
616
+66%
|
338
-45%
|
|
| Liabilities | |||||||||
| Accounts Payable |
1
|
2
|
2
|
4
|
3
|
5
|
5
|
2
|
|
| Accrued Liabilities |
1
|
2
|
5
|
8
|
13
|
18
|
22
|
15
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
10
|
0
|
0
|
0
|
1
|
1
|
0
|
4
|
|
| Total Current Liabilities |
12
|
5
|
7
|
12
|
17
|
24
|
27
|
20
|
|
| Long-Term Debt |
2
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
1
|
1
|
0
|
13
|
13
|
17
|
14
|
|
| Total Liabilities |
15
N/A
|
11
-29%
|
8
-27%
|
12
+57%
|
29
+143%
|
38
+29%
|
44
+17%
|
35
-21%
|
|
| Equity | |||||||||
| Common Stock |
20
|
20
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
7
|
20
|
65
|
124
|
228
|
381
|
569
|
482
|
|
| Additional Paid In Capital |
0
|
0
|
327
|
367
|
506
|
714
|
1 140
|
1 169
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
385
|
|
| Total Equity |
13
N/A
|
1
-96%
|
262
+52 240%
|
243
-7%
|
277
+14%
|
332
+20%
|
572
+72%
|
303
-47%
|
|
| Total Liabilities & Equity |
27
N/A
|
11
-60%
|
269
+2 349%
|
255
-5%
|
307
+20%
|
370
+21%
|
616
+66%
|
338
-45%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
19
|
19
|
23
|
24
|
28
|
32
|
41
|
20
|
|
Switch to:
Switch to:
See Also
Discover More
